Hypothesis Intermittent low‑grade hormetic stress triggers a transient, NAD+-sparing stress response that preferentially activates autophagy and SIRT1 via AMPK‑mediated mTORC1 inhibition; however, repeated or sustained hormetic exposure leads to cumulative PARP‑driven NAD+ consumption, resulting in NAD+ depletion, impaired sirtuin activity, and accelerated epigenetic drift, ultimately shortening lifespan despite short‑term stress resistance.

Mechanistic Rationale

• Hormetic stimuli (e.g., mild heat, low‑dose ROS, brief fasting) activate AMPK, which inhibits mTORC1 and upregulates ULK1‑dependent autophagyCalabrese et al., 2024.
• AMPK activation also increases NAD+ biosynthesis by stimulating NAMPT, temporarily boosting the NAD+/NADH ratio and enhancing SIRT1 deacetylase activityBroSkey et al., 2019.
• The same low‑level stress generates modest DNA damage, activating PARP1. PARP consumes NAD+ to polymerize ADP‑ribose chains on histones and repair proteins.Sun et al., 2020.
• With intermittent exposure, the NAD+ boost from AMPK outweighs PARP consumption, yielding a net NAD+ surplus that supports sirtuin‑mediated deacetylation of FOXO and PGC‑1α, promoting stress resistance and autophagy.
• With chronic or frequent hormetic intervals, PARP activation becomes recurrent, depleting the NAD+ pool faster than salvage pathways can replenish it. NAD+ decline reduces SIRT1 activity, leading to hyperacetylation of chromatin, loss of heterochromatin stability, and accelerated epigenetic drift—a hallmark of aging.Blagosklonny, 2011
• Depleted NAD+ also impairs mitochondrial sirtuins (SIRT3/SIRT5), decreasing oxidative phosphorylation efficiency and increasing ROS production, creating a maladaptive feed‑forward loop.

Testable Predictions

1. In model organisms (e.g., C. elegans or mice), an intermittent hormesis regimen (e.g., 2 h heat shock every 48 h) will increase lifespan and NAD+ levels compared with ad libitum controls, whereas a continuous low‑dose hormesis regimen (e.g., constant mild heat) will shorten lifespan and reduce NAD+.
2. Pharmacological inhibition of PARP (e.g., with olaparib) during chronic hormesis will rescue NAD+ levels and extend lifespan, confirming that PARP‑mediated NAD+ consumption drives the deleterious effect.
3. Tissue‑specific SIRT1 overexpression will mitigate the lifespan‑shortening effect of chronic hormesis, indicating that sirtuin activity is downstream of NAD+ status.
4. Epigenetic clocks (e.g., Horvath’s mouse clock) will show accelerated epigenetic age in animals subjected to chronic hormesis, but not in those receiving intermittent hormesis, even if both groups exhibit comparable acute stress‑resistance markers (e.g., HSP70 induction).

Experimental Design

• Groups (n = 30 per group, male/female balanced):
  • Control (no stress)
  • Intermittent hormesis (2 h 36 °C heat shock q48h)
  • Chronic hormesis (continuous 34 °C ambient)
  • Chronic hormesis + PARP inhibitor
  • Chronic hormesis + muscle‑specific SIRT1 transgene
• Measurements (taken at weeks 4, 8, 12):
  • NAD+/NADH ratio (LC‑MS)
  • SIRT1 activity (fluorometric deacetylase assay)
  • Autophagic flux (LC3‑II/I ratio with bafilomycin A1)
  • DNA damage (γH2AX foci)
  • Lifespan (survival curves)
  • Epigenetic age (bisulfite sequencing of CpG sites)
• Analysis: Two‑way ANOVA for treatment × time, Kaplan‑Meier for survival, post‑hoc Tukey tests; significance set at p < 0.05.

Potential Confounds & Controls

• Ensure that temperature fluctuations do not cause hypothermia; monitor core temperature continuously.
• Verify that PARP inhibitor does not independently affect hormetic signaling via off‑target AMPK effects (include AMPK inhibitor control).
• Control for possible caloric intake differences caused by stress‑induced anorexia; pair‑feed control group to match intake of stressed groups.

Implications If validated, this hypothesis reframes hormesis not as a generic longevity promoter but as a temporal balancing act: the same stress‑response pathways that confer short‑term resilience can become pro‑aging when NAD+ recycling is overwhelmed. It suggests that longevity interventions should optimize the interval and intensity of hormetic stimuli to preserve NAD+ homeostasis, aligning with emerging strategies that combine NAD+ boosters (e.g., NR, NMN) with periodized fasting or exercise regimens.